FDA issues authorization for first molecular non-prescription, at-home COVID-19 test
by Press Release from Outbreak News Today on (#5F0P1)
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Cue COVID-19 Test for Home and Over The Counter (OTC) Use. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus present in the nostrils. The test is the first molecular [...]
The post FDA issues authorization for first molecular non-prescription, at-home COVID-19 test appeared first on Outbreak News Today.